Cargando…

Prognostic Significance and Functional Role of CEP57 in Prostate Cancer()

We have recently shown that centrosomal protein 57 (CEP57) is overexpressed in a subset of human prostate cancers. CEP57 is involved in intracellular transport processes, and its overexpression causes mitotic defects as well as abnormal microtubule nucleation and bundling. In the present study, we f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mang, Josef, Korzeniewski, Nina, Dietrich, Dimo, Sailer, Verena, Tolstov, Yanis, Searcy, Sam, von Hardenberg, Jost, Perner, Sven, Kristiansen, Glen, Marx, Alexander, Roth, Wilfried, Herpel, Esther, Grüllich, Carsten, Popeneciu, Valentin, Pahernik, Sascha, Hadaschik, Boris, Hohenfellner, Markus, Duensing, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2015
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700294/ https://www.ncbi.nlm.nih.gov/pubmed/26692530 http://dx.doi.org/10.1016/j.tranon.2015.11.004

Ejemplares similares

Harnessing the p53-PUMA Axis to Overcome DNA Damage Resistance in Renal Cell Carcinoma()
por: Zhou, Xiaoguang, et al.
Publicado: (2014)

Uncoupling of PUMA Expression and Apoptosis Contributes to Functional Heterogeneity in Renal Cell Carcinoma — Prognostic and Translational Implications()
por: Zhou, Xiaoguang, et al.
Publicado: (2015)

Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
por: Hoefflin, Rouven, et al.
Publicado: (2016)

Genomic features of renal cell carcinoma with venous tumor thrombus
por: Warsow, Gregor, et al.
Publicado: (2018)

Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression
por: Pickl, Julia M.A., et al.
Publicado: (2016)

Efficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German Centers
por: Zschäbitz, Stefanie, et al.
Publicado: (2017)

Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL
por: Dieffenbacher, Svenja, et al.
Publicado: (2018)

Cep57 and Cep57L1 maintain centriole engagement in interphase to ensure centriole duplication cycle
por: Ito, Kei K., et al.
Publicado: (2021)

The ribosomal protein S6 in renal cell carcinoma: functional relevance and potential as biomarker
por: Knoll, Maximilian, et al.
Publicado: (2015)

Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer
por: Hatiboglu, G., et al.
Publicado: (2017)

Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy
por: Dietz, Steffen, et al.
Publicado: (2017)

Correlation between genomic index lesions and mpMRI and (68)Ga-PSMA-PET/CT imaging features in primary prostate cancer
por: Kesch, Claudia, et al.
Publicado: (2018)

MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive marker
por: Macher-Goeppinger, Stephan, et al.
Publicado: (2016)

Cullin 5 is a novel candidate tumor suppressor in renal cell carcinoma involved in the maintenance of genome stability
por: Tapia-Laliena, María Ángeles, et al.
Publicado: (2019)

Mutations in CEP57 cause mosaic variegated aneuploidy syndrome
por: Snape, Katie, et al.
Publicado: (2011)

Paraganglioma of the Seminal Vesicle Case Report and Review of the Literature
por: Tosev, Georgi, et al.
Publicado: (2016)

The Cep57-pericentrin module organizes PCM expansion and centriole engagement
por: Watanabe, Koki, et al.
Publicado: (2019)

Volumetry may predict early renal function after nephron sparing surgery in solitary kidney patients
por: Kuru, Timur H, et al.
Publicado: (2014)

Daughter Centriole Elongation Is Controlled by Proteolysis
por: Korzeniewski, Nina, et al.
Publicado: (2010)

Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017)

Mosaic-variegated aneuploidy syndrome mutation or haploinsufficiency in Cep57 impairs tumor suppression
por: Aziz, Khaled, et al.
Publicado: (2018)

Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery
por: Li, Jielin, et al.
Publicado: (2021)

Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition
por: Dietrich, Dimo, et al.
Publicado: (2013)

A novel role of the aryl hydrocarbon receptor (AhR) in centrosome amplification - implications for chemoprevention
por: Korzeniewski, Nina, et al.
Publicado: (2010)

The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression
por: Korzeniewski, Nina, et al.
Publicado: (2011)

Mutations in BRCA2 and taxane resistance in prostate cancer
por: Nientiedt, Cathleen, et al.
Publicado: (2017)

miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells
por: Bauer, Simone, et al.
Publicado: (2021)

Primary melanoma of the prostate: case report and review of the literature
por: Tosev, Georgi, et al.
Publicado: (2015)

PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
por: Gevensleben, Heidrun, et al.
Publicado: (2016)

Mosaic variegated aneuploidy syndrome caused by a CEP57 mutation diagnosed by whole exome sequencing
por: Brightman, Diana S., et al.
Publicado: (2018)

Survival outcomes of patients with germ cell tumors treated with high-dose chemotherapy for refractory or relapsing disease
por: Zschäbitz, Stefanie, et al.
Publicado: (2018)

TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells
por: Ratz, Leonie, et al.
Publicado: (2017)

Multiparametric magnetic resonance tomography and MRI/TRUS-fusion-biopsy for index lesion detection: correlation with radical prostatectomy specimen
por: Radtke, JP, et al.
Publicado: (2015)

Cep70 and Cep131 contribute to ciliogenesis in zebrafish embryos
por: Wilkinson, Christopher J, et al.
Publicado: (2009)

Cep63 and Cep152 Cooperate to Ensure Centriole Duplication
por: Brown, Nicola J., et al.
Publicado: (2013)

Copy number variation in CEP57L1 predisposes to congenital absence of bilateral ACL and PCL ligaments
por: Liu, Yichuan, et al.
Publicado: (2015)

Double homozygosity in CEP57 and DYNC2H1 genes detected by WES: Composite or expanded phenotype?
por: Pezzani, Lidia, et al.
Publicado: (2020)

Clinical characteristics, treatment outcomes and potential novel therapeutic options for patients with neuroendocrine carcinoma of the prostate
por: Apostolidis, Leonidas, et al.
Publicado: (2019)

Erratum to: Copy number variation in CEP57L1 predisposes to congenital absence of bilateral ACL and PCL ligaments
por: Liu, Yichuan, et al.
Publicado: (2016)

Cep57 is a Mis12-interacting kinetochore protein involved in kinetochore targeting of Mad1–Mad2
por: Zhou, Haining, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lk9fvkanbu1tt8ignugelkq09v